Hepatopulmonary Syndrome clinical trials at UCSF

1 in progress, 0 open to eligible people

Letrozole in Patients With Hepatopulmonary Syndrome:A Double-Blind Randomized Clinical Trial
Sorry, not yet accepting patients
The purpose of this study is to assess the safety, tolerability and possible benefit of letrozole compared to placebo in patients with Hepatopulmonary Syndrome.
San Francisco, California and other locations

Last updated: September 30, 2020